IBDEI20P ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34228,1,4,0)
 ;;=4^N41.9
 ;;^UTILITY(U,$J,358.3,34228,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,34229,0)
 ;;=N70.91^^131^1682^75
 ;;^UTILITY(U,$J,358.3,34229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34229,1,3,0)
 ;;=3^Salpingitis,Unspec
 ;;^UTILITY(U,$J,358.3,34229,1,4,0)
 ;;=4^N70.91
 ;;^UTILITY(U,$J,358.3,34229,2)
 ;;=^5015806
 ;;^UTILITY(U,$J,358.3,34230,0)
 ;;=N70.93^^131^1682^74
 ;;^UTILITY(U,$J,358.3,34230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34230,1,3,0)
 ;;=3^Salpingitis & Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,34230,1,4,0)
 ;;=4^N70.93
 ;;^UTILITY(U,$J,358.3,34230,2)
 ;;=^5015808
 ;;^UTILITY(U,$J,358.3,34231,0)
 ;;=N70.92^^131^1682^55
 ;;^UTILITY(U,$J,358.3,34231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34231,1,3,0)
 ;;=3^Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,34231,1,4,0)
 ;;=4^N70.92
 ;;^UTILITY(U,$J,358.3,34231,2)
 ;;=^5015807
 ;;^UTILITY(U,$J,358.3,34232,0)
 ;;=N73.9^^131^1682^37
 ;;^UTILITY(U,$J,358.3,34232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34232,1,3,0)
 ;;=3^Inflammatory Disease Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,34232,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,34232,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,34233,0)
 ;;=A56.11^^131^1682^36
 ;;^UTILITY(U,$J,358.3,34233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34233,1,3,0)
 ;;=3^Inflammatory Disease Chlamydial Female Pelvic
 ;;^UTILITY(U,$J,358.3,34233,1,4,0)
 ;;=4^A56.11
 ;;^UTILITY(U,$J,358.3,34233,2)
 ;;=^5000342
 ;;^UTILITY(U,$J,358.3,34234,0)
 ;;=N73.5^^131^1682^64
 ;;^UTILITY(U,$J,358.3,34234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34234,1,3,0)
 ;;=3^Peritonitis Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,34234,1,4,0)
 ;;=4^N73.5
 ;;^UTILITY(U,$J,358.3,34234,2)
 ;;=^5015817
 ;;^UTILITY(U,$J,358.3,34235,0)
 ;;=N72.^^131^1682^35
 ;;^UTILITY(U,$J,358.3,34235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34235,1,3,0)
 ;;=3^Inflammatory Disease Cervix Uteri
 ;;^UTILITY(U,$J,358.3,34235,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,34235,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,34236,0)
 ;;=N76.3^^131^1682^92
 ;;^UTILITY(U,$J,358.3,34236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34236,1,3,0)
 ;;=3^Vulvitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,34236,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,34236,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,34237,0)
 ;;=N76.1^^131^1682^88
 ;;^UTILITY(U,$J,358.3,34237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34237,1,3,0)
 ;;=3^Vaginitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,34237,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,34237,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,34238,0)
 ;;=N76.2^^131^1682^91
 ;;^UTILITY(U,$J,358.3,34238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34238,1,3,0)
 ;;=3^Vulvitis,Acute
 ;;^UTILITY(U,$J,358.3,34238,1,4,0)
 ;;=4^N76.2
 ;;^UTILITY(U,$J,358.3,34238,2)
 ;;=^5015828
 ;;^UTILITY(U,$J,358.3,34239,0)
 ;;=N76.0^^131^1682^87
 ;;^UTILITY(U,$J,358.3,34239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34239,1,3,0)
 ;;=3^Vaginitis,Acute
 ;;^UTILITY(U,$J,358.3,34239,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,34239,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,34240,0)
 ;;=M00.20^^131^1682^3
 ;;^UTILITY(U,$J,358.3,34240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34240,1,3,0)
 ;;=3^Arthritis Streptococcal,Unspec Joint
 ;;^UTILITY(U,$J,358.3,34240,1,4,0)
 ;;=4^M00.20
 ;;^UTILITY(U,$J,358.3,34240,2)
 ;;=^5009645
 ;;^UTILITY(U,$J,358.3,34241,0)
 ;;=M00.80^^131^1682^4
 ;;^UTILITY(U,$J,358.3,34241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34241,1,3,0)
 ;;=3^Arthritis d/t Bacteria,Unspec Joint
 ;;^UTILITY(U,$J,358.3,34241,1,4,0)
 ;;=4^M00.80
